Showing results (51-60 of 274) with videos related to

Sort By:
Pageof 28
Revista Espanola De Cardiologia|September 9, 2008
Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance studyPedro Morillas, Jesús Castillo, Juan Quiles, et al.
Medicina Clinica|December 29, 2009
[Long-term prognosis of serum and urine n-terminal proBNP levels and glomerular filtration rate in heart failure patients]Raquel Cortés, Miguel Rivera, Luís Martínez-Dolz, et al.
Cardiovascular Research|October 13, 2009
Influence of heart failure on nucleocytoplasmic transport in human cardiomyocytesRaquel Cortés, Esther Roselló-Lletí, Miguel Rivera, et al.
International Journal of Pharmaceutics|May 11, 2018
Elucidation of the orientation of selected drugs with 2-hydroxylpropyl-β-cyclodextrin using 2D-NMR spectroscopy and molecular modelingSaugat Adhikari, Saloni Daftardar, Filip Fratev, et al.
British Journal of Clinical Pharmacology|June 30, 2021
Number needed to treat for net effect of anticoagulation in atrial fibrillation: Real-world vs. clinical-trial evidenceWern Yew Ding, José Miguel Rivera-Caravaca, Francisco Marín, et al.
Journal of General Internal Medicine|April 12, 2022
The Atrial Fibrillation Better Care (ABC) Pathway and Clinical Outcomes in Patients with Atrial Fibrillation: the Prospective Murcia AF Project Phase II CohortJosé Miguel Rivera-Caravaca, Vanessa Roldán, Lorena Martínez-Montesinos, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|March 22, 2021
Short- and medium-term complications after emergency department treatment of patients with atrial fibrillation: design and internal validation of the CoSTuM risk scaleJoaquín Valle Alonso, José Miguel Rivera-Caravaca, Francisco Javier Fonseca, et al.
The American Journal of Clinical Nutrition|January 1, 2026
Prognostic value of adiposity indices in anticoagulated patients with atrial fibrillation: The prospective Murcia AF Project III cohortEva Soler-Espejo, Yang Chen, Vanessa Roldán, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|June 9, 2021
Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviewsStephanie L Harrison, Benjamin J R Buckley, José Miguel Rivera-Caravaca, et al.
Revista Espanola De Cardiologia|November 6, 2009
Urinary NT-proBNP. A valuable marker in the assessment of patients with essential hypertensionEsther Roselló-Lletí, Miguel Rivera, Raquel Cortés, et al.
Pageof 28